Telmisartan Market 2028 By Product, Application and Geography | The Insight Partners

    Telmisartan Market Forecast to 2028 - Covid-19 Impact and Global Analysis - Indication (Hypertension, Cardiac Arrest, Stroke); Composition (Single, Combinational); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

    Report Code: TIPRE00005565 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

    MARKET INTRODUCTION


    Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.

    MARKET DYNAMICS


    The global Telmisartan market is expected to grow in upcoming years. Factors driving the growth of market are increasing prevalence of high blood pressure, increase in incidences of chronic diseases such as diabetes, growth in geriatric population and others. On the other hand rise on approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets is expected to offer growth opportunities in telmisartan market.

    MARKET SCOPE


    The "Global Telmisartan Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Telmisartan market with detailed market segmentation by indication, composition, distribution channel and geography. The global Telmisartan market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION


    The global Telmisartan markets is segmented on the basis of indication, composition and distribution channel. Based on indication, the market is segmented as hypertension, cardiac arrest and stroke. Based on composition the Telmisartan market is segmented into single and combinational. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

    Get more information on this report :

    REGIONAL FRAMEWORK


    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Telmisartan market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Telmisartan market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting Telmisartan market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Telmisartan market in these regions.

    Get more information on this report :

    MARKET PLAYERS


    The reports cover key developments in the Telmisartan market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Telmisartan market are anticipated to lucrative growth opportunities in the future with the rising demand for Telmisartan in the global market. Below mentioned is the list of few companies engaged in the Telmisartan market.

    The report also includes the profiles of key Telmisartan market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
    • Mylan N.V.
    • Hikma Pharmaceuticals PLC
    • Exelan Pharmaceuticals, Inc.
    • Macleods Pharmaceuticals Ltd.
    • Zydus Pharmaceuticals, Inc.
    • Torrent Pharmaceuticals Ltd.
    • Jubilant Cadista.
    • Aurobindo Pharma.
    • Solco Healthcare
    • Sandoz International GmbH
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Telmisartan Market - By Indication
    1.3.2 Telmisartan Market - By Composition
    1.3.3 Telmisartan Market - By Distribution Channel
    1.3.4 Telmisartan Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. TELMISARTAN MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.3. EXPERT OPINIONS
    5. TELMISARTAN MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
    6. TELMISARTAN MARKET - GLOBAL MARKET ANALYSIS
    6.1. TELMISARTAN - GLOBAL MARKET OVERVIEW
    6.2. TELMISARTAN - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE
    7. TELMISARTAN MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
    7.1. OVERVIEW
    7.2. INDICATION MARKET FORECASTS AND ANALYSIS
    7.3. HYPERTENSION
    7.3.1. Overview
    7.3.2. Hypertension Market Forecast and Analysis
    7.4. CARDIAC ARREST
    7.4.1. Overview
    7.4.2. Cardiac Arrest Market Forecast and Analysis
    7.5. STROKE
    7.5.1. Overview
    7.5.2. Stroke Market Forecast and Analysis
    8. TELMISARTAN MARKET - REVENUE AND FORECASTS TO 2028 - COMPOSITION
    8.1. OVERVIEW
    8.2. COMPOSITION MARKET FORECASTS AND ANALYSIS
    8.3. SINGLE
    8.3.1. Overview
    8.3.2. Single Market Forecast and Analysis
    8.4. COMBINATIONAL
    8.4.1. Overview
    8.4.2. Combinational Market Forecast and Analysis
    9. TELMISARTAN MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    9.1. OVERVIEW
    9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITAL PHARMACIES
    9.3.1. Overview
    9.3.2. Hospital Pharmacies Market Forecast and Analysis
    9.4. RETAIL PHARMACIES
    9.4.1. Overview
    9.4.2. Retail Pharmacies Market Forecast and Analysis
    9.5. ONLINE PHARMACIES
    9.5.1. Overview
    9.5.2. Online Pharmacies Market Forecast and Analysis
    10. TELMISARTAN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Telmisartan Market Overview
    10.1.2 North America Telmisartan Market Forecasts and Analysis
    10.1.3 North America Telmisartan Market Forecasts and Analysis - By Indication
    10.1.4 North America Telmisartan Market Forecasts and Analysis - By Composition
    10.1.5 North America Telmisartan Market Forecasts and Analysis - By Distribution Channel
    10.1.6 North America Telmisartan Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Telmisartan Market
    10.1.6.1.1 United States Telmisartan Market by Indication
    10.1.6.1.2 United States Telmisartan Market by Composition
    10.1.6.1.3 United States Telmisartan Market by Distribution Channel
    10.1.6.2 Canada Telmisartan Market
    10.1.6.2.1 Canada Telmisartan Market by Indication
    10.1.6.2.2 Canada Telmisartan Market by Composition
    10.1.6.2.3 Canada Telmisartan Market by Distribution Channel
    10.1.6.3 Mexico Telmisartan Market
    10.1.6.3.1 Mexico Telmisartan Market by Indication
    10.1.6.3.2 Mexico Telmisartan Market by Composition
    10.1.6.3.3 Mexico Telmisartan Market by Distribution Channel
    10.2. EUROPE
    10.2.1 Europe Telmisartan Market Overview
    10.2.2 Europe Telmisartan Market Forecasts and Analysis
    10.2.3 Europe Telmisartan Market Forecasts and Analysis - By Indication
    10.2.4 Europe Telmisartan Market Forecasts and Analysis - By Composition
    10.2.5 Europe Telmisartan Market Forecasts and Analysis - By Distribution Channel
    10.2.6 Europe Telmisartan Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Telmisartan Market
    10.2.6.1.1 Germany Telmisartan Market by Indication
    10.2.6.1.2 Germany Telmisartan Market by Composition
    10.2.6.1.3 Germany Telmisartan Market by Distribution Channel
    10.2.6.2 France Telmisartan Market
    10.2.6.2.1 France Telmisartan Market by Indication
    10.2.6.2.2 France Telmisartan Market by Composition
    10.2.6.2.3 France Telmisartan Market by Distribution Channel
    10.2.6.3 Italy Telmisartan Market
    10.2.6.3.1 Italy Telmisartan Market by Indication
    10.2.6.3.2 Italy Telmisartan Market by Composition
    10.2.6.3.3 Italy Telmisartan Market by Distribution Channel
    10.2.6.4 Spain Telmisartan Market
    10.2.6.4.1 Spain Telmisartan Market by Indication
    10.2.6.4.2 Spain Telmisartan Market by Composition
    10.2.6.4.3 Spain Telmisartan Market by Distribution Channel
    10.2.6.5 United Kingdom Telmisartan Market
    10.2.6.5.1 United Kingdom Telmisartan Market by Indication
    10.2.6.5.2 United Kingdom Telmisartan Market by Composition
    10.2.6.5.3 United Kingdom Telmisartan Market by Distribution Channel
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Telmisartan Market Overview
    10.3.2 Asia-Pacific Telmisartan Market Forecasts and Analysis
    10.3.3 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Indication
    10.3.4 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Composition
    10.3.5 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Distribution Channel
    10.3.6 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Telmisartan Market
    10.3.6.1.1 Australia Telmisartan Market by Indication
    10.3.6.1.2 Australia Telmisartan Market by Composition
    10.3.6.1.3 Australia Telmisartan Market by Distribution Channel
    10.3.6.2 China Telmisartan Market
    10.3.6.2.1 China Telmisartan Market by Indication
    10.3.6.2.2 China Telmisartan Market by Composition
    10.3.6.2.3 China Telmisartan Market by Distribution Channel
    10.3.6.3 India Telmisartan Market
    10.3.6.3.1 India Telmisartan Market by Indication
    10.3.6.3.2 India Telmisartan Market by Composition
    10.3.6.3.3 India Telmisartan Market by Distribution Channel
    10.3.6.4 Japan Telmisartan Market
    10.3.6.4.1 Japan Telmisartan Market by Indication
    10.3.6.4.2 Japan Telmisartan Market by Composition
    10.3.6.4.3 Japan Telmisartan Market by Distribution Channel
    10.3.6.5 South Korea Telmisartan Market
    10.3.6.5.1 South Korea Telmisartan Market by Indication
    10.3.6.5.2 South Korea Telmisartan Market by Composition
    10.3.6.5.3 South Korea Telmisartan Market by Distribution Channel
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Telmisartan Market Overview
    10.4.2 Middle East and Africa Telmisartan Market Forecasts and Analysis
    10.4.3 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Indication
    10.4.4 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Composition
    10.4.5 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Distribution Channel
    10.4.6 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Telmisartan Market
    10.4.6.1.1 South Africa Telmisartan Market by Indication
    10.4.6.1.2 South Africa Telmisartan Market by Composition
    10.4.6.1.3 South Africa Telmisartan Market by Distribution Channel
    10.4.6.2 Saudi Arabia Telmisartan Market
    10.4.6.2.1 Saudi Arabia Telmisartan Market by Indication
    10.4.6.2.2 Saudi Arabia Telmisartan Market by Composition
    10.4.6.2.3 Saudi Arabia Telmisartan Market by Distribution Channel
    10.4.6.3 U.A.E Telmisartan Market
    10.4.6.3.1 U.A.E Telmisartan Market by Indication
    10.4.6.3.2 U.A.E Telmisartan Market by Composition
    10.4.6.3.3 U.A.E Telmisartan Market by Distribution Channel
    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    12. TELMISARTAN MARKET, KEY COMPANY PROFILES
    12.1. MYLAN N.V.
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. HIKMA PHARMACEUTICALS PLC
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. EXELAN PHARMACEUTICALS, INC.
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. MACLEODS PHARMACEUTICALS LTD.
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. ZYDUS PHARMACEUTICALS, INC.
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. TORRENT PHARMACEUTICALS LTD.
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. JUBILANT CADISTA.
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. AUROBINDO PHARMA.
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. SOLCO HEALTHCARE
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. SANDOZ INTERNATIONAL GMBH
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments
    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    1. Mylan N.V.
    2. Hikma Pharmaceuticals PLC
    3. Exelan Pharmaceuticals, Inc.
    4. Macleods Pharmaceuticals Ltd.
    5. Zydus Pharmaceuticals, Inc.
    6. Torrent Pharmaceuticals Ltd.
    7. Jubilant Cadista.
    8. Aurobindo Pharma.
    9. Solco Healthcare
    10. Sandoz International GmbH
    TIPRE00005565
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount